PolyPhotonix Limited and embecta UK have announced they have signed a co-promotional agreement un...

We can support our patients with diabetic retinopathy throughout their treatment with Noctur...

If you’re enjoying relaxing over the festive period and want an informative read about Noctura ...

Telegraph featuring us over Christmas – and to let everyone know that Noctura 400 is now availa...

We’re really happy that Noctura 400 is now available on the NHS, and it’s great to be feature...

PolyPhotonix were at Stand E02, Diabetes Professional Care event, London last week, showing off t...

Noctura 400 is featured in a Daily Mail report explaining the cost saving it could bring if adopt...

During Diabetes Week 2022 on TopDoctorsUK, the Chief Investigator of a recent successful Noctura ...

CEO Richard Kirk talks about the development and successes of Noctura 400. With an in depth under...